RxDoctor Payments Data

Jennifer Seifert, DPM

Podiatrist · Newark, DENPI 1114284106

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (48.8%), education and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Liberty Surgical Inc. at 39.6% of the total. Reporting peaked in 2019 at $3,298 and has fallen 94.1% since, to $194 in 2025. Among podiatrist clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$12,482in general payments, 2019–2025

Across 137 payments — averaging $91.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Liberty Surgical Inc.$5K
  • Stryker$5K
  • Osteomed LLC$1K
  • Arthrex$499
  • Smith+Nephew$227
  • Johnson & Johnson$157
  • plus $905 from 14 others

What the payments were for

  • Travel & lodging$2,78222%
  • Food & beverage$6,09249%
  • Education$3,60829%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Liberty Surgical Inc.19$4,939
Stryker66$4,502
Osteomed LLC11$1,253
Arthrex10$499
Smith+Nephew4$227
Johnson & Johnson2$157
Medtronic2$156
Abbott1$155
Bioventus LLC5$152
Zimmer Biomet3$145
Eclipse Technology Solutions Inc.3$93
Medshape, Inc.1$75
Melinta Therapeutics, LLC3$47
Carbofix Orthopedics Inc1$16
TEI Medical Inc.1$15
Osiris Therapeutics Inc.1$14
Acell, Inc.1$14
DJO, LLC1$11
Paragon 28, Inc.1$8
Kerecis Limited1$3

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,482 in reported general payments places this provider in the 95th percentile of 37 podiatrist providers in Delaware.

See all podiatrist providers in Delaware

Medicare billing

Part B allowed, 2024
$134,216
Medicare patients
379
Services billed
1,876

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam149$855
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav23$705
Ondansetron Hcl36$276
Methylprednisolone33$264
Gabapentin61$230
Diclofenac Sodium13$170
Oxycodone Hcl41$156
Doxycycline Hyclate13$121
Mupirocin19$121
Acetaminophen-CodeineAcetaminophen With Codeine16$78

Paid to pharmacies, not to this prescriber.

Other podiatrist in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →